Has pancreatic cancer met its match?
Last month, the Food and Drug Administration approved a new drug for one of the deadliest cancers, lending new hope to patients whose treatment options had…
Section
Last month, the Food and Drug Administration approved a new drug for one of the deadliest cancers, lending new hope to patients whose treatment options had…
Part of the Wondering series A series of random questions answered by Harvard experts. Deirdre Leigh Barrett is a dream researcher and a Harvard Medical School…
A series focused on the personal side of Harvard research and teaching. Joan Brugge was on track to graduate from Northwestern University in a few years…
Parents are spending twice as much time with their children as they did 50 years ago, according to some estimates. For the increasing numbers of people…
The hip joint is a well-known point of failure in the human body, especially as we age. It’s no wonder the problem is familiar: In the…
Getting old is inevitable. But getting sick as we get old is not. That was the message of the first annual Healthy Aging Symposium, hosted by…
How can words make us laugh? Make us cry? During Nobel laureate Karl Deisseroth’s time at the College, the question went from a matter of literature…
GLP-1s were created to treat Type 2 diabetes. But since their discovery as a tool for fighting obesity, they have surged in popularity. As of last…
You’ve probably heard some version of the message: “Don’t be a quitter.” But in journalist Lindsay Crouse’s new book, “The Case for Quitting: The Surprising Benefits…
The celebration looked like a typical party, complete with a frosted cake and candles, but for Stefan Catanach, the sweetness represented something far deeper than dessert.…